Treatment for severe altitude sickness
Part of Lungs & breathing clinical trials.
This trial tests new ways to diagnose and treat severe altitude sickness, which can cause fluid in the lungs or swelling in the brain. It aims to improve care for people who get very sick after climbing to high altitudes quickly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with severe altitude sickness, including fluid in the lungs or swelling in the brain.
- You are between 18 and 75 years old.
- You climbed to an altitude above 8,200 feet (2,500 meters) within the last 72 hours before getting sick.
- You do not have severe heart or lung disease, cancer, or serious liver or kidney problems.
- You are not pregnant and do not have a mental health condition that would make it hard to follow the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.
This trial tests if inhaled nitric oxide helps people with high-altitude pulmonary edema (fluid in the lungs from high altitude). It may offer a new treatment option for those with mild to moderate symptoms.
This trial studies “erythrocytapheresis,” a procedure that filters part of the blood, to improve symptoms of chronic mountain sickness caused by long-term living at high altitude. It may help people with high-altitude–related headaches, dizziness, shortness of breath, poor sleep, fatigue, and related signs.
This trial tests if Advair HFA affects how likely someone is to develop High Altitude Pulmonary Edema (HAPE), a serious lung condition at high altitudes. It compares people who are prone to HAPE, those who are resistant, and healthy controls.
This study looks at how the right side of the heart responds to low oxygen levels in people who have had high altitude pulmonary edema (HAPE) in the past. It will help researchers better understand right heart function.
This study looks at high-altitude polycythemia, a condition where your body makes too many red blood cells because of living at high altitude. Researchers want to learn more about it, so they are inviting people with this condition to participate.
Hear when a new Severe High Altitude Pulmonary Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.